Sign in

CIK 0001590877

  • Non-accelerated filer
  • Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
Operating
EIN
471851754
Phone
+1 240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
Open-market buys, last 90 days
$949,381
in 1 filing
Open-market sales, last 90 days
$0
in 0 filings

Net +$949,381. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Ciongoli Gregory Austin +$949K Director 1 filing

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2018-09-17 Vasista Vittal Chief Financial Officer Exercise or conversion · Employee Stock Option (Right to Buy) −30,000 204,900
2018-09-17 Mills Kenneth T. President and CEO Sale −1,515 $70.46 $107K 339,505
2018-09-17 Mills Kenneth T. President and CEO Sale −100 $71.10 $7K 339,405
2018-09-17 Mills Kenneth T. President and CEO Sale −624 $73.04 $46K 338,781
2018-09-17 Mills Kenneth T. President and CEO Sale −1,399 $73.80 $103K 337,382
2018-09-17 Mills Kenneth T. President and CEO Sale −622 $75.29 $47K 336,760
2018-09-17 Mills Kenneth T. President and CEO Sale −1,450 $76.72 $111K 335,310
2018-09-17 Mills Kenneth T. President and CEO Sale −900 $77.88 $70K 334,410
2018-09-17 Mills Kenneth T. President and CEO Sale −400 $78.73 $31K 334,010
2018-09-17 Mills Kenneth T. President and CEO Sale −200 $79.45 $16K 333,810
2018-09-17 Mills Kenneth T. President and CEO Sale −300 $81.12 $24K 333,510
2018-08-27 Mills Kenneth T. President and CEO Exercise or conversion +145,000 $0.85 $123K 348,530
2018-08-27 Mills Kenneth T. President and CEO Sale −5,757 $66.29 $382K 342,773
2018-08-27 Mills Kenneth T. President and CEO Sale −1,753 $67.02 $117K 341,020
2018-08-27 Mills Kenneth T. President and CEO Exercise or conversion · Employee Stock Option (Right to Buy) −145,000 234,670
2018-08-20 Christmas Patrick J. SVP, General Counsel Exercise or conversion +5,000 $12.10 $61K 22,669
2018-08-20 Christmas Patrick J. SVP, General Counsel Sale −3,400 $65.75 $224K 19,269
2018-08-20 Christmas Patrick J. SVP, General Counsel Sale −1,600 $66.41 $106K 17,669
2018-08-20 Christmas Patrick J. SVP, General Counsel Exercise or conversion · Employee Stock Option (Right to Buy) −5,000 63,472
2018-08-15 Vasista Vittal Chief Financial Officer Sale −6,199 $65.31 $405K 123,584

Page 39 of 43 · 852 trades